LT position PART 1
Portfolio Positions acquired: $RNA $DAWN $SLNO $NARI $BPMC $MYOV base:0x9bba915f036158582c20b51113b925f243a1a1a1 $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML base:0x4e6c9f48f73e54ee5f3ab7e2992b2d733d0d0b07 $CMRX $RLYP $ITCI $KVUE
Tech positions: In order
$AMZN $META $NVDA $MSFT $SOFI $GOOGL $RDDT $MELI $APP $RKLB $INTC $IREN $NBIS $CRDO $AAOI $BE $AXON $MDB
Biotech positions: $VKTX $CYTK $ARDX $HROW $MDGL $CRVS $ABVX $TMDX $RVMD $NKTR $CELC $AVR
Pharmdca retweeted
Bernie Sanders: "Democrats are working with Trump to pass a bill that fast tracks data center construction" - $NBIS $IREN $CRWV $NVDA
Voters said NO to data centers in the election.
Now some Democrats are working with Trump to pass a bill that fast tracks data center construction and gives more handouts to the fossil fuel industry. Really?
NO to Big Oil. NO to data centers. NO to their permitting bill.
Readers added context they thought people might want to know
The Senate-passed BAAJA bill speeds energy project permitting, which critics say aids data centers and fossil fuels. It also requires large data centers to cover their own grid costs, protecting ratepayers.
usatoday.com/story/news/pol…
energy.senate.gov/press/dem/fact…
Pharmdca retweeted
Potential blockbuster M&A in cybersecurity.
Bloomberg reporting that $CRWD is in talks to buy $ZS.
Would give the endpoint titan (& so much more now) a lot more muscle in network.
Would give CrowdStrike a far more complete product suite to match $PANW's breadth too.
While Zscaler may be struggling a bit to expand to other categories... they are world-class in network. CrowdStrike is world-class in a lot of other things.
Seems like a good fit.
Pharmdca retweeted
You weren't Warren Buffett 2.0 on the way up.
You are not an idiot today.
We are both somewhere firmly in between.
And as long as we're acting responsibly, that's entirely fine. We will be fine.
There will be brighter days. Great companies will not get cheaper forever.
$ABVX In a nutshell from my investing experience in Biotech sector.
It takes years of execution, clinical success, and capital allocation to build value in a company and garner investor confidence. Yet it can take just one short report to inject uncertainty and erase months of progress in the eyes of the market.
Destroying sentiment can take a single short report.
14
7,434
$RVMD clearing event. Stock down on anticipation of $ERAS data this morning.
Pullback is a good opportunity to add $RVMD demonstrating a clear transitioning into commercial stage post drug launch with revenue of $198 million in just 5 weeks (partial quarter).
Company is moving into transformational period with no competition for next few years and to expand into earlier clinical settings and validation across other cancers like NSCLC etc.
1
11
7,073
Pharmdca retweeted
SANDISK $SNDK 8-FOR-1 STOCK SPLIT IS NOW EFFECTIVE







